Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Horizon Discovery, Boehringer in Research Alliance | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Horizon Discovery, Boehringer in Research Alliance

Will support BI’s drug discovery programs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Horizon Discovery has signed a research service collaboration with Boehringer Ingelheim to support BI’s oncology programs using its Discovery Toolbox for research projects and profiling of compounds from hit-to-lead to preclinical stages. Financial terms were not disclosed.
 
Horizon will evaluate compounds across a broad panel of X-MAN isogenic models and selected 2D/3D phenotypic assays, and will provide an FTE and access to its custom cell line generation services to support the programs. Horizon will also apply its genome editing technology GENESIS to develop human isogenic disease model cell lines according to Boehringer’s specifications.
 
Kam Dhaliwal, vice president of sales, Horizon, said “We are delighted that Boehringer Ingelheim has selected Horizon as a partner for its drug discovery programs, in recognition of the value our X-MAN cell lines and drug discovery services can add to the search for novel treatments for cancer.”
 

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics